Patient-Reported Outcomes in Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Patient-Reported Outcomes in Rheumatoid Arthritis

Published:2016-05 Issue:2 Volume:42 Page:219-237
ISSN:0889-857X
Container-title:Rheumatic Disease Clinics of North America
language:en
Short-container-title:Rheumatic Disease Clinics of North America

Author:

van Tuyl Lilian H.D.,Michaud Kaleb

Publisher

Elsevier BV

Subject

Rheumatology

Reference140 articles.

1. Guidance for industry: patient-reported outcome measures: use in medical product development to support labeling claims: draft guidance;US Department of Health and Human Services FDA Center for Drug Evaluation and Research;Health Qual Life Outcomes,2006

2. Reporting disease activity in clinical trials of patients with rheumatoid arthritis: EULAR/ACR collaborative recommendations;Aletaha;Ann Rheum Dis,2008

3. World Health Organization and International League of Associations for rheumatology core endpoints for symptom modifying antirheumatic drugs in rheumatoid arthritis clinical trials;Boers;J Rheumatol Suppl,1994

4. American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis;Felson;Arthritis Rheum,1995

5. Does social disadvantage contribute to the excess mortality in rheumatoid arthritis patients?;Maiden;Ann Rheum Dis,1999

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Critical importance of patient-reported outcomes for a comprehensive assessment of psoriatic arthritis patients;Frontiers in Medicine;2024-01-16

2. How Russian patients with rheumatoid arthritis assess their condition: initial data from the OPTIMA (Patient Assessment of Severity, Outcomes and Medical Care in Arthritis) pilot study;Modern Rheumatology Journal;2023-12-19

3. Telemonitoring for the management of patients with rheumatoid arthritis or psoriatic arthritis: A qualitative survey;International Journal of Rheumatic Diseases;2023-11-07

4. Experience with the interleukin 6 inhibitor (Olokizumab) in patients with rheumatoid arthritis in real clinical practice: Influence on inflammatory activity and disease outcomes;Rheumatology Science and Practice;2023-10-31

5. Contribution of the factors to EuroQol 5 Dimensions in rheumatoid arthritis patients achieving low disease activity/remission with abatacept treatment: Post hoc subgroup analyses of the Japanese real-world observational ‘ORIGAMI’ study;Modern Rheumatology;2023-08-24